Related changes
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are shown in bold with a green bullet. See more at Help:Related changes.
List of abbreviations (help):
- D
- Edit made at Wikidata
- r
- Edit flagged by ORES
- N
- New page
- m
- Minor edit
- b
- Bot edit
- (±123)
- Page byte size change
- Temporarily watched page
1 June 2024
- diffhist Lorlatinib 18:09 +627 Lfstevens talk contribs (trial vs crizotinib) Tag: Visual edit
- diffhist Template:Targeted cancer therapeutic agents 03:51 +91 Whywhenwhohow talk contribs (add entries)
- diffhist Sugemalimab 03:47 +4 Whywhenwhohow talk contribs (add wl)
- diffhist Template:Monoclonals for tumors 03:46 +18 Whywhenwhohow talk contribs (add Sugemalimab)
- diffhist N Sugemalimab 03:45 +6,655 Whywhenwhohow talk contribs (create)
- diffhist Aflibercept 03:37 −54 Boghog talk contribs (consistent citation formatting)
- diffhist Lorlatinib 02:17 0 150.220.112.59 talk (→Approval: Fixed typo) Tags: Mobile edit Mobile web edit
- diffhist Tarlatamab 00:40 +15 Lfstevens talk contribs (→top: extended scale) Tag: Visual edit
31 May 2024
- diffhist World Health Organization 23:07 −4 HeyElliott talk contribs (MOS:SOB) Tag: 2017 wikitext editor
- diffhist Bevacizumab 20:58 +811 Whywhenwhohow talk contribs (add pending EU)
- diffhist Bevacizumab 20:13 +37 Whywhenwhohow talk contribs (add bevacizumab gamma)
- diffhist Bevacizumab 20:12 +101 Whywhenwhohow talk contribs (add Lytenava)
- diffhist Tarlatamab 19:50 +149 Whywhenwhohow talk contribs (update ref)
- diffhist Lorlatinib 15:38 0 89.247.174.120 talk (→Side effects: fixed grammar (led to, not led in))
- diffhist m CD20 12:58 −1 Neils51 talk contribs (sp)
- diffhist World Health Organization 03:42 −186 HeyElliott talk contribs (MOS:B) Tag: 2017 wikitext editor
30 May 2024
- diffhist World Health Organization 13:24 −978 Mx. Granger talk contribs (partial revert - an off-the-cuff statement by a politician is not a reliable source for this, and the WHO's own reports show different figures - https://cdn.who.int/media/docs/default-source/results-reports/who-results-report-programme-budget-2016-2017.pdf)
- diffhist World Health Organization 07:08 +475 2.196.179.0 talk (→Private funding: Bill & Melinda Gates Foundation)
- diffhist World Health Organization 07:00 +465 2.196.179.0 talk (→Private funding)
- diffhist World Health Organization 06:57 +549 2.196.179.0 talk (→Regional offices: private funding (new section))
- diffhist m Leukemia 00:48 +24 Picantho talk contribs (link Central nervous system prophylaxis; cleaned up using AutoEd)
29 May 2024
- diffhist Phases of clinical research 20:17 −1 Niafied talk contribs
- diffhist CD20 12:15 −45 Boghog talk contribs (per WP:HEAD, simplify section headings (no reason to repeat title of article in every heading); sentence case for section headings)
- diffhist m CD20 12:08 +130 Boghog talk contribs (Replaced VE ref names using RefRenamer)
- diffhist CD20 12:07 −626 Boghog talk contribs (consistent citation formatting)
- diffhist m CD20 11:43 +18 Bohumil Ptacek talk contribs Tag: Visual edit
- diffhist CD20 11:39 +4,172 Bohumil Ptacek talk contribs Tag: Visual edit
- diffhist Lymphatic system 02:35 +29 31.218.84.22 talk (Updated short description #article-change-desc) Tags: Mobile edit Mobile app edit iOS app edit
28 May 2024
- diffhist Standard for the Uniform Scheduling of Medicines and Poisons 02:17 −9 119.17.50.210 talk (→References) Tag: Visual edit
27 May 2024
- diffhist m World Health Organization 14:24 −3 Mx. Granger talk contribs (Reverted edits by 124.171.157.227 (talk) to last version by ClueBot NG) Tag: Rollback
- diffhist Food and Drug Administration 10:39 +268 Red Book Librarian talk contribs (→Generic drugs: +WebMD)
- diffhist World Health Organization 07:07 +2 124.171.157.227 talk Tag: Reverted
- diffhist World Health Organization 07:06 +1 124.171.157.227 talk Tag: Reverted
26 May 2024
- diffhist Monoclonal antibody 06:45 +24 Hanif Al Husaini talk contribs (→COVID-19: Mention COVID-19 in the beginning)